Should Norepinephrine, Rather than Phenylephrine, Be Considered the Primary Vasopressor in Anesthetic Practice?
From the Department of Anesthesiology and Perioperative Medicine, Pennsylvania State University, College of Medicine, Hershey Medical Center, Hershey, Pennsylvania.
Berend
B
Mets
D000768:Anesthesia, General / Q000009:adverse effects*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D006801:Humans; D007022:Hypotension / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D009638:Norepinephrine / Q000009:adverse effects / Q000627:therapeutic use*; D010656:Phenylephrine / Q000009:adverse effects / Q000627:therapeutic use*; D012307:Risk Factors; D016896:Treatment Outcome; D014661:Vasoconstriction / Q000187:drug effects*; D014662:Vasoconstrictor Agents / Q000009:adverse effects / Q000627:therapeutic use*
D014662:Vasoconstrictor Agents; D010656:Phenylephrine; D009638:Norepinephrine